Thoracic Oncology

It is our pleasure to invite you to participate in The European Congress on Thoracic Oncology to take place 12-13 November 2026 in Rotterdam, The Netherlands.

Thoracic-Oncology2026 will focus on the latest developments and findings in the diagnosis, management and treatment of thoracic oncological diseases. The Congress will present treatments available on the market as well as treatments still in the development stage, with emphasis on the basic and translational research ongoing.

The congress will focus on the following key areas:

• Progress in the treatment of advanced stage disease lung cancer
• Separate sections will discuss novel treatments in oncogene addicted lung cancer and immunotherapy
• Novel treatment options in stage III small cell and non small cell lung cancer
• The role of  neo-adjuvant and peri-operative immunotherapy
• The future of the treatment of non oncogene addicted lung cancer
• The current treatment paradigm of mesothelioma and thymoma

You are invited and encouraged to contribute to the program by submitting an abstract for oral and e-poster presentation and we look forward to your active participation.

The Congress will welcome Oncologists, Pulmonologists, Thoracic surgeons, Pathologists, Radiologists, Nurses, Healthcare Professionals, R&D Personnel, CEOs, Research Facility Managers, Pharmaceutical Representatives and Start-Up Companies.

Please join us at Thoracic-Oncology2026 in the modern and vibrant city of Rotterdam.

Best regards,